Clinical Trials Browser

Phase 1/2 × NSCLC × aflutinib × Clear all

NCT05994131 2025-04-30

IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC

Phase 1/2 Recruiting

NSCLC